Financhill
Back

Envestnet Vs. Keros Therapeutics Industry Stock Comparison

Sell
50

ENV
Envestnet

Last Price:
61.97
Seasonality Move:
-2.44%
Buy
66

KROS
Keros Therapeutics

Last Price:
49.74
Seasonality Move:
16.51%
Sell
50
Envestnet (ENV) is a Sell

Is Envestnet a Buy, Sell or Hold?

  • The current Envestnet [ENV] share price is $61.84. The Score for ENV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ENV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $50.82. The Score for KROS is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ENV Stock Price Chart

What is Envestnet's stock price today?

  • The Envestnet share price today is $61.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENV is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $50.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ENV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 576556 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.54 - 62.7) Sell
Bollinger Bands (100): (56.65 - 65.35) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 60.14 Buy
Chaikin Money Flow: 281726 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.12 - 48.88) Buy
Bollinger Bands (100): (47.03 - 63.59) Sell

ENV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.65 Buy
20-day SMA: 62.1 Sell
50-day SMA: 63.79 Sell
200-day SMA: 52.96 Buy
8-day EMA: 61.75 Buy
20-day EMA: 62.07 Sell
50-day EMA: 62.26 Sell
200-day EMA: 57.4 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.52 Buy
20-day SMA: 46.13 Buy
50-day SMA: 48.03 Buy
200-day SMA: 48.13 Buy
8-day EMA: 48.75 Buy
20-day EMA: 47.51 Buy
50-day EMA: 48.96 Buy
200-day EMA: 49.47 Buy

Envestnet Earnings Growth & ENV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.69 per share, and an increase next year of $0.42 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Envestnet Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):